Researchers have analyzed novel grape-derived compounds, dihydrocaffeic acid (DHCA) and malvidin-3'-O-glucoside (Mal-gluc), which might be developed as therapeutic agents for the treatment of depression. Their study results indicate that these natural compounds may attenuate depression by targeting newly discovered underlying mechanisms of the disease.